Anti-MLLT11 antibody [CHCR115] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal MLLT11 antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
AF1Q, MLLT11, Protein AF1q
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MLLT11 antibody [CHCR115] - BSA and Azide free (AB247747)
This data was developed using ab109016, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of MLLT11 expression in paraffin-embedded Human thymus tissue using ab109016 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-MLLT11 antibody [CHCR115] - BSA and Azide free (AB247747)
This data was developed using ab109016, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-MLLT11 antibody [CHCR115] (<a href='/en-us/products/primary-antibodies/mllt11-antibody-chcr115-ab109016'>ab109016</a>) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
Molt4 cell lysate at 10 µg
Predicted band size: 10 kDa,36 kDa
false
Reactivity data
Product details
ab247747 is the carrier-free version of ab109016.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MLLT11 participates in chromatin remodeling and transcriptional elongation. This protein forms part of the super elongation complex (SEC) which includes other essential transcription-related proteins like P-TEFb and AF4/FMR2. The presence of MLLT11 in the SEC facilitates the elongation phase of transcription ensuring proper gene expression needed for cellular differentiation and proliferation processes.
Pathways
MLLT11 plays a significant role in the regulation of gene expression pathways particularly the transcriptional misregulation in cancer pathway. Its involvement in these pathways supports the proper function of transcriptional regulation machinery through interactions with proteins such as DOT1L and AF9. These interactions are necessary for the maintenance of transcriptional fidelity across various biological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 26:409 PubMed37600337
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com